2005Unpublished venueRequires access

83 Bi Bismuth‐Based Pharmaceuticals

Neil Burford, Melanie D. Eelman

Open publisher page 2 citations

Abstract

This chapter contains sections titled: Introduction Bismuth-Based Therapeutics Fundamental Aspects of Bismuth Chemistry and Methods of Characterization Hydroxycarboxylate Complexes of Bismuth Development of Bioactive Bismuth Compounds Interactions of Bismuth Compounds with Biological Molecules Concluding Remarks References

About this research paper

What this paper is about

This chapter contains sections titled: Introduction Bismuth-Based Therapeutics Fundamental Aspects of Bismuth Chemistry and Methods of Characterization Hydroxycarboxylate Complexes of Bismuth Development of Bioactive Bismuth Compounds Interactions of Bismuth Compounds with Biological Molecules Concluding Remarks References

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This chapter contains sections titled: Introduction Bismuth-Based Therapeutics Fundamental Aspects of Bismuth Chemistry and Methods of Characterization Hydroxycarboxylate Complexes of Bismuth Development of Bioactive Bismuth Compounds Interactions of Bismuth Compounds with Biological Molecules Concluding Remarks References

Key concepts: Bismuth, Chemistry, Characterization (materials science), Nanotechnology, Materials science, Organic chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
83 Bi Bismuth‐Based Pharmaceuticals — Research Paper | ScholarLens